{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:31:52Z","timestamp":1793377912882,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of War","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.07.033","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:33:15Z","timestamp":1784356395000},"page":"5858-5871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A singular base-editing platform for polyfunctional multiplex engineering of immune cells"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-5949","authenticated-orcid":false,"given":"Joseph G.","family":"Skeate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Slipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walker S.","family":"Lahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambojit","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce J.","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibekananda","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Woong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Stelljes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria K.","family":"Gilkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek P.","family":"Thenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miechaleen D.","family":"Diers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan M.","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara-lin","family":"Lonetree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell G.","family":"Kluesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendell","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo P.","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branden S.","family":"Moriarity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-8747","authenticated-orcid":false,"given":"Beau R.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.033_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","article-title":"CAR immune cells: design principles, resistance and the next generation","volume":"614","author":"Labanieh","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.033_bib2","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1038\/srep08150","article-title":"Optimized tuning of TALEN specificity using non-conventional RVDs","volume":"5","author":"Juillerat","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.07.033_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.omtn.2017.10.005","article-title":"Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy","volume":"9","author":"Gautron","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.07.033_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13578-019-0304-0","article-title":"Multiplexed CRISPR\/Cas9 gene knockout with simple crRNA:tracrRNA co-transfection","volume":"9","author":"Khan","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ymthe.2026.07.033_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.07.033_bib6","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1038\/s41467-021-26097-y","article-title":"Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing","volume":"12","author":"Papathanasiou","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.033_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mt.2015.197","article-title":"Evaluation of TCR gene editing achieved by TALENs, CRISPR\/Cas9, and megaTAL nucleases","volume":"24","author":"Osborn","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.033_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-019-09006-2","article-title":"CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations","volume":"10","author":"Cullot","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.033_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1186\/s12967-024-05957-3","article-title":"From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine","volume":"22","author":"Xu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib13","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41467-021-22009-2","article-title":"CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells","volume":"12","author":"Kluesner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.033_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13059-018-1482-5","article-title":"CRISPR-SKIP: programmable gene splicing with single base editors","volume":"19","author":"Gapinske","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib15","doi-asserted-by":"crossref","first-page":"10354","DOI":"10.1038\/s41467-024-54529-y","article-title":"SPLICER: a highly efficient base editing toolbox that enables in vivo therapeutic exon skipping","volume":"15","author":"Miskalis","year":"2024","journal-title":"Nat Commun."},{"key":"10.1016\/j.ymthe.2026.07.033_bib16","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1038\/s41467-019-13007-6","article-title":"Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors","volume":"10","author":"Webber","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.033_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009560","article-title":"Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.07.033_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2427216122","article-title":"Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR\/Cas9 nuclease-engineered T cells","volume":"122","author":"Engel","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.033_bib19","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.ymthe.2026.03.007","article-title":"Efficient multiplex non-viral engineering and expansion of polyclonal \u03b3\u03b4 CAR-T cells for immunotherapy","volume":"34","author":"Bridge","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.033_bib20","article-title":"Installation of dominant-negative mutations in FAS and TGF\u03b2R2 via base editing in primary T cells","volume":"33","author":"Wick","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s44321-024-00183-2","article-title":"CAR T-cell-associated secondary malignancies challenge current pharmacovigilance concepts","volume":"17","author":"Berg","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa2309728","article-title":"CAR+ T-cell lymphoma after cilta-cel therapy for relapsed or refractory myeloma","volume":"392","author":"Harrison","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJMoa2411507","article-title":"CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53","volume":"392","author":"Perica","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib25","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood.2024024166","article-title":"Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System","volume":"143","author":"Elsallab","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.033_bib26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41587-022-01527-4","article-title":"Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases","volume":"41","author":"Yarnall","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41587-022-01574-x","article-title":"Precise cut-and-paste DNA insertion using engineered type V-K CRISPR-associated transposases","volume":"41","author":"Tou","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib28","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41551-023-01157-4","article-title":"Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair","volume":"8","author":"Webber","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.07.033_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.033_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13059-023-02928-7","article-title":"Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells","volume":"24","author":"Glaser","year":"2023","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib31","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41587-022-01377-0","article-title":"Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nbt.3101","article-title":"Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases","volume":"33","author":"Frock","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib33","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.033_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm9106","article-title":"Precise CRISPR-Cas-mediated gene repair with minimal off-target and unintended on-target mutations in human hematopoietic stem cells","volume":"8","author":"Tran","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.07.033_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib36","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1038\/s41467-022-29868-3","article-title":"Double-tap gene drive uses iterative genome targeting to help overcome resistance alleles","volume":"13","author":"Bishop","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.033_bib37","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1038\/s41467-022-31944-7","article-title":"Recursive Editing improves homology-directed repair through retargeting of undesired outcomes","volume":"13","author":"M\u00f6ller","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.033_bib38","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41467-022-29989-9","article-title":"Targeting double-strand break indel byproducts with secondary guide RNAs improves Cas9 HDR-mediated genome editing efficiencies","volume":"13","author":"Bodai","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.033_bib39","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.5966\/sctm.2015-0049","article-title":"Targeted Disruption of the \u03b22-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib40","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.medj.2022.07.008","article-title":"Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade","volume":"3","author":"Palmer","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.ymthe.2026.07.033_bib41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41598-017-00462-8","article-title":"CRISPR\/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells","volume":"7","author":"Rupp","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.07.033_bib42","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood.2020005185","article-title":"Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR\/Cas9-mediated TCR knockout CAR","volume":"136","author":"Stenger","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.033_bib43","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1096\/fj.201800636R","article-title":"Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression","volume":"33","author":"Brehm","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2026.07.033_bib44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s13059-024-03434-0","article-title":"Adenine base editors induce off-target structure variations in mouse embryos and primary human T cells","volume":"25","author":"Wu","year":"2024","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1126\/science.aav9973","article-title":"Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos","volume":"364","author":"Zuo","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.07.033_bib46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","article-title":"Long-term outcomes following CAR T cell therapy: what we know so far","volume":"20","author":"Cappell","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib47","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41591-024-02826-w","article-title":"T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy","volume":"30","author":"Ghilardi","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib48","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood.2021010858","article-title":"Investigation of product derived lymphoma following infusion of piggyBac modified CD19 chimeric antigen receptor T-cells","volume":"138","author":"Micklethwaite","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.033_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41576-021-00329-9","article-title":"Genetic engineering of T cells for immunotherapy","volume":"22","author":"Ellis","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2026.07.033_bib51","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41409-020-0956-8","article-title":"Value and affordability of CAR T-cell therapy in the United States","volume":"55","author":"Fiorenza","year":"2020","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.ymthe.2026.07.033_bib52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41587-022-01418-8","article-title":"High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails","volume":"41","author":"Shy","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.omtm.2021.10.008","article-title":"Multiplex CRISPR\/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations","volume":"23","author":"Samuelson","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.033_bib54","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13059-021-02462-4","article-title":"Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion","volume":"22","author":"Wen","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib55","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1038\/s41375-021-01282-6","article-title":"Base-edited CAR T cells for combinational therapy against T cell malignancies","volume":"35","author":"Georgiadis","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2026.07.033_bib56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.033_bib57","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.ymthe.2024.06.033","article-title":"An aptamer-mediated base editing platform for simultaneous knock-in and multiple gene knockout for allogeneic CAR-T cells generation","volume":"32","author":"Porreca","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.033_bib58","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt.2675","article-title":"CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering","volume":"31","author":"Mali","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib59","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.21037\/atm-21-1948","article-title":"A narrative review of tumor heterogeneity and challenges to tumor drug therapy","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib60","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood.2020008503","article-title":"Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem\/progenitor cells","volume":"137","author":"De Ravin","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.033_bib61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.34172\/bi.2022.23871","article-title":"Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems","volume":"12","author":"Shams","year":"2022","journal-title":"Bioimpacts"},{"key":"10.1016\/j.ymthe.2026.07.033_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt.4021","article-title":"Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency","volume":"36","author":"Canny","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/crispr.2018.0014","article-title":"EditR: A Method to Quantify Base Editing from Sanger Sequencing","volume":"1","author":"Kluesner","year":"2018","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.07.033_bib64","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.033_bib65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/jpm11020142","article-title":"Identification of somatic structural variants in solid tumors by optical genome mapping","volume":"11","author":"Goldrich","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ymthe.2026.07.033_bib66","doi-asserted-by":"crossref","first-page":"101644","DOI":"10.1016\/j.omtm.2025.101644","article-title":"Unveiling genomic rearrangements in engineered iPSC lines by optical genome mapping","volume":"33","author":"Finlay","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.033_bib67","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1002\/cpsc.57","article-title":"Cancer stem cell migration in three-dimensional aligned collagen matrices","volume":"46","author":"Ray","year":"2018","journal-title":"Curr. Protoc. Stem Cell Biol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:36:05Z","timestamp":1793374565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525001626006015"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.033","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A singular base-editing platform for polyfunctional multiplex engineering of immune cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}